크로세틴 에스테르 시장 규모와 점유율 분석 : 용도별(기능성 식품 및 음료, 의약품) - 세계 매출 추산과 수요 예측(-2030년)

Key Highlights

The crocetin esters market was valued at USD 411.3 thousand in 2023, and it will increase to USD 634.3 thousand, advancing at a 6.5% compound annual growth rate, by 2030.

This is because of the increasing interest in plant-based and natural items as a replacement for synthetic ingredients in functional foods and dietary supplements.

The rising trends of health & wellness, growing consumer consciousness, the regulatory situation, and the usage of these chemicals in nutrition and medicine are also helping the industry expand.

The continuing studies to explore the health benefits and viable applications of crocetin esters are further assisting the growth of the industry.

These mixtures are being examined for their possible role in decreasing oxidative stress, supporting cognitive well-being, and controlling CVDs.

The rising populace and the requirement to enhance food production are also aiding the growth of this industry.

With limited arable land in well-urbanized nations, it has become vital to enhance the productivity of the present farmlands.

Crocetin esters assist in optimizing the accessibility of nutrients for plants by reducing their draining, thus enhancing plant development, which can result in greater crop yields.

Market Insights

Europe accounted for the largest share of the industry in 2023, with a 45% share.

The dominance of this region in the enduring understanding of saffron as well as its acceptance.

Saffron, from which crocetin esters are produced, has been farmed in various areas of this region for quite a long time, notably in Italy, Greece, and Spain.

APAC will advance at the fastest compound annual growth rate, of 10%, in the years to come.

This will be because of the region's rising need for functional foods & beverages and the growing concentration of the medical benefits linked to antioxidants.

Natural as well as functional food ingredients are in high demand because customers in APAC nations become more conscious of their well-being.

The functional food and beverage category accounted for the largest share of the industry in 2023, with a 60% share.

Crocetin esters are progressively being employed in confectionery, dairy, beverages, and convenience foods, because of their important part in protecting these products' stability.

They, similarly, assist in increasing the taste, aroma, and assortment of food & beverages.

Functional foods fulfill people's everyday nutrition requirements, as a result, customers are increasingly searching for them for their overall wellbeing.

Pharmaceuticals will advance at a rapid compound annual growth rate, of 8%, in the years to come.

Due to the robust anti-inflammatory, neuroprotective, and antioxidant features of crocetin esters, pharmaceutical firms have been progressively using them as APIs or various other ingredients in the formulations of drugs.

A growing count of clinical trials and studies are being performed on these bioactive substances to explore their possible therapeutic applications for cardiovascular illnesses, neurological disorders, and tumors.

In the crocetin esters industry, competition circles around the introduction of saffron-derived extracts and research on applications of these mixtures in cosmetics, functional foods, and pharmaceuticals.

The competition in this industry is rather tough, with the existence of several globally operating and localized participants.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by application
  • 1.4.2. Market size breakdown, by region
  • 1.4.3. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Application (2017-2030)
• 6.3. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Application (2017-2030)
• 7.3. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Application (2017-2030)
• 8.3. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Application (2017-2030)
• 9.3. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Application (2017-2030)
• 10.3. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Application (2017-2030)
• 11.3. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Application (2017-2030)
• 12.3. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Application (2017-2030)
• 13.3. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Application (2017-2030)
• 14.3. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Application (2017-2030)
• 15.3. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Chengdu Biopurify Phytochemicals Ltd.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Chengdu Gelipu Biotechnology Co. Ltd.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Tokyo Chemical Industry Co. Ltd
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Amadis Chemical Company Limited
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Hunan Jiahang Pharmaceutical Technology Co. Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Cayman Chemical
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Biosynth
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Plamed Green Science Group
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Shaanxi UndersunBiomedtech Co. Ltd.
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Chongqing Kang Biotechnology Co. Ltd.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Hainan Super Biotech Co. Ltd.
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Xi'an Sgonek Biological Technology Co. Ltd.
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary
• 30.13. Kingherbs Limited
  • 30.13.1. Business overview
  • 30.13.2. Product and service offerings
  • 30.13.3. Key financial summary
• 30.14. Xi'an Lyphar Biotech Co. Ltd.
  • 30.14.1. Business overview
  • 30.14.2. Product and service offerings
  • 30.14.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports